ALL NEWS TODAY

[ ALL NEWS TODAY ]

Pfizer And Ranbaxy Settle Lipitor Patent Litigation Worldwide

Pfizer Inc announced that it has entered into an agreement with generics manufacturer Ranbaxy Laboratories Ltd. of India and certain of its affiliates to settle substantially all their patent litigation worldwide involving Lipitor, the world's most-prescribed cholesterol-lowering medicine. Under the terms of the agreement, Ranbaxy will have a license to sell generic versions of Lipitor and Caduet in the United States effective November 30, 2011.
Comments: [0] / Post comment:
08 Jan 2009 01:08:17

Sanjay Gupta Treads the Ethical Line - The Plank on TNR.com

Sanjay Gupta Treads the Ethical Line The Plank on TNR.com, DC - In a November 2003 broadcast of CNNs American Morning, Gupta described the benefits of the cholesterol-reducing drug Lipitor , which is produced by ...
07 Jan 2009 19:54:03

Critics Cupboard: Spam slices - Corning Leader

Critics Cupboard: Spam slices Corning Leader, NY - ... to eat two with double cheese, onion, tomato and lettuce on a toasted sesame seed bun with mayo and mustard and a double dose of Lipitor and Prilosec. ...
07 Jan 2009 19:22:54

Pfizer Keeps Open Mind for Acquisitions - WiredPRNews.com (press release)

Pfizer Keeps Open Mind for Acquisitions WiredPRNews.com (press release), TX - As noted by Reuters, revenue decreases are anticipated in 2011 for one of the companys top selling cholesterol medications, Lipitor , which generates $12 ... Pfizer open to acquiring other Big Pharma firms, CEO says
07 Jan 2009 14:08:39

Technical defect in Pfizer patent on Lipitor corrected - MiamiHerald.com

Technical defect in Pfizer patent on Lipitor corrected MiamiHerald.com, FL - A US Patent & Trademark Office decision to correct a technical defect in one of the patents involving Pfizer's (PFE) cholesterol medicine Lipitor maintains ...
07 Jan 2009 02:49:41

TO THE POINT - Investor's Business Daily (subscription)

TO THE POINT Investor's Business Daily (subscription) - The Patent Office said it will accept the drug maker's application to correct a technical defect in one of the patents covering its cholesterol drug Lipitor ...
07 Jan 2009 01:50:18

The You Docs: Get smarter in six minutes - Seattle Post Intelligencer

The You Docs: Get smarter in six minutes Seattle Post Intelligencer - ... of cheap mustard or a curry dish daily, and ask your doc about a nonbrain-crossing statin drug (such as Lipitor or Crestor) or high-dose niacin. ...
07 Jan 2009 00:30:14

Pfizer: US ruling maintains Lipitor patent term - The Associated Press

Pfizer: US ruling maintains Lipitor patent term The Associated Press - The decision will result in reissuance of the drug's key patent and maintain that patent's June 2011 expiration date, crucial to Pfizer because Lipitor ... Pfizer Wins New Lipitor Patent Expiring in June 2011 Pharma Roundup: Pfizers Lipitor Patent, Wyeth and Crucell, and More Pfizer allowed to correct error in key Lipitor patent -
06 Jan 2009 23:23:56

Meat Me by the Park: Viande moves to Laurelhurst? - Willamette Week

Meat Me by the Park: Viande moves to Laurelhurst? Willamette Week, OR - I'm a dead manI might as well start taking Lipitor now. Illustrations in the proposal indicate the new business, if approved, will have outdoor seating on ...
05 Jan 2009 18:30:00

Pfizer's Potential Buys, Big and Small - TheStreet.com

Post Chronicle Pfizer's Potential Buys, Big and Small TheStreet.com - Pfizer has big needs, namely a drug or several to replace the projected loss of revenue coming in 2011 when its leading anti-cholesterol drug Lipitor goes ... Finding cures for corporate ills Pfizer chief open to acquisitions: report Pfizer (PFE) Will Consider Merger With Larger Rival -
05 Jan 2009 16:37:41

Warning: Patent cliff approaching - FiercePharma

Warning: Patent cliff approaching FiercePharma, DC - Case in point: Lipitor . Settling a long-running patent dispute, Pfizer and Ranbaxy Laboratories came up with a mutual back-scratching deal under which ...

Keywords:

ALL NEWS TODAY © PoznaiSebya.Com
Designer Padayatra Dmytriy